STAT+

Health tech Andrew Joseph

STAT Plus: U.K. researchers warn about biases in medical devices, health care algorithms

Exclusive Bob Herman

STAT Plus: UnitedHealth is on a buying spree of outpatient surgery centers

Business Brittany Trang

STAT Plus: Medicare announces loan program to aid providers affected by Change cyberattack

Biotech Adam Feuerstein and Damian Garde

STAT Plus: Amylyx ALS drug failure leaves patients, advocates, and researchers reeling — and wondering what’s next

Pharma Elaine Chen

STAT Plus: Obesity drug Wegovy gets FDA approval to add cardiovascular benefits on its label

Business Tara Bannow

STAT Plus: UnitedHealth gives timeline for Change restoration: payments up by late next week

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Lilly Alzheimer’s drug adcomm, Amylyx ALS drug flop, and more

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Biotech Andrew Joseph

STAT Plus: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug

Matt's Take Matthew Herper

STAT Plus: Biden’s SOTU highlights pharma’s biggest political problem: It is terrifyingly, awfully alone

First Opinion Amit Etkin

STAT Plus: It’s time to rethink everything about our approach to psychiatric drug development

Politics Rachel Cohrs

STAT Plus: Pharma giants, government spar in court over Medicare drug price negotiation

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more

Health tech Lizzy Lawrence

STAT Plus: Former medical device CEO who sold dummy, plastic parts convicted of fraud

Biotech Allison DeAngelis

STAT Plus: Novo Nordisk’s obesity pill bests Wegovy in early trial

Pharmalot Ed Silverman

STAT Plus: Boehringer Ingelheim to cap asthma inhaler out-of-pocket costs at $35

Business Brittany Trang

STAT Plus: Nursing home owners can hide nearly two-thirds of their profits, new study shows

Biotech Adam Feuerstein

STAT Plus: A deep dive into Applied Therapeutics’ data, and questions on Cassava’s erased data

Politics John Wilkerson

STAT Plus: Senate panel advances bill to ban some Chinese biotechs, with Sen. Paul taking up industry’s cause

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about HIV drug resistance, march-in rights, and more

Biotech Allison DeAngelis

STAT Plus: Startup Alumis raises $259 million as it prepares for psoriasis trial

Health tech Mario Aguilar

STAT Plus: With Meta’s backing, Headspace launches into VR

Politics John Wilkerson

STAT Plus: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices

Health tech Mohana Ravindranath

STAT Plus: Oracle Health chair says Cerner isn’t competing with Epic

Health tech Katie Palmer and Lizzy Lawrence

STAT Plus: FDA clears first over-the-counter continuous glucose monitor

Insurance Tara Bannow

STAT Plus: Large insurers say up to one-quarter of claims run through Change Healthcare

In the Lab Megan Molteni

STAT Plus: Harvard longevity scientist sparks furor with claim about reversing aging in dogs

Pharmalot Ed Silverman

STAT Plus: WTO proposal for Covid diagnostics and therapeutics waiver is abandoned

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more